Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, ChristianaCare is implementing a temporary visitation age restriction starting Tuesday, Jan. 21. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.

Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, ChristianaCare está implementando una restricción temporal en la edad de visitantes a partir del viernes 21 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Breast Cancer Research Program

The mere thought of breast cancer strikes fear in every woman, regardless of race, culture or socioeconomic background. Even with ever-more promising treatment options, we can’t help but share the worry. Will it be me? Will her cancer come back? Can we ever truly stop worrying about breast cancer?

At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, doctors, nurses, scientists and community educators are working together through the Breast Cancer Research Program on cutting-edge studies to discover new and better ways to prevent breast cancer, find it earlier, treat it more effectively and improve both survival rates and quality of life. They are also working to determine why certain populations of women have higher rates of some types of cancer and why outcomes vary among different groups; to identify novel biomarkers that may help us understand who is most likely to get certain cancers or to have a recurrence; and to increase the number of minority women who participate in promising translational research studies

This multidisciplinary team of experts — including leading scientific researchers from the University of Delaware and The Wistar Institute in Philadelphia — translates discoveries newly made in the lab into tests and treatments that improve the lives of women facing breast cancer. From a revolutionary blood screening test with the potential to determine whether cancer is present and likely to spread, to targeted therapies to improve survival outcomes and decrease chemotherapy side effects for women with triple negative breast cancer, to developing new treatments for aggressive breast cancers, the Breast Cancer Research Program is harnessing new technologies and leading-edge advances to advance the science of breast cancer medicine.

The innovative partnerships made possible by ChristianaCare’s Breast Cancer Research Program ensure that cutting-edge diagnostic tools, treatments and services are accessible to every woman in Delaware. We are also building partnerships with community leaders and those with first-hand knowledge of breast cancer through the Community Research Advisory Board to help identify research opportunities that will directly impact the needs of our community and to promote the importance of breast health education and participation in clinical trials.